Press release
Neoantigen Targeted Therapies Market: Towering Growth, Key Players, and Emerging Trends
Neoantigen Targeted Therapies Market Share
The neoantigen targeted therapies market has been growing significantly and is projected to continue this trend.
•2024 Market Size: $3.4 billion
•2025 Market Size: $4.72 billion (38.7% CAGR)
•2029 Market Size: $16.01 billion (35.7% CAGR)
These developments owe much to advancements in genomic sequencing, immunotherapy evolution, understanding tumor immunology, molecular profiling advancements among others.
What Is Driving The Growth In The Neoantigen Targeted Therapies Market?
The striking rise in cancer cases worldwide is a major catalyst propelling the growth of the neoantigen targeted therapies market. The incidence of cancer refers to the number of new cancer cases reported within a certain period in a specific population. Neoantigen-targeted therapies are often combined with other treatments to tackle different cancer types. Records from the American Cancer Society shows that in 2022, there were about 1.9 million new cancer cases in the United States, a considerably higher figure compared to previous years. More so, it was estimated that 609,360 deaths in the US were as a result of cancer. Thus, the escalating incidence of cancer cases is indeed a primary driver for the neoantigen targeted therapies market.
Request A Free Sample Copy:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11944&type=smp
Who Are the Key Players Driving Neoantigen Targeted Therapies Market Growth?
•F. Hoffmann-La Roche AG
•Merck and Co. Inc.
•Bristol Myers Squibb Company
•Eli Lilly and Company
•Kite Pharma Inc., Gilead Sciences Inc.
•Amgen Inc.
•Moderna Inc.
•BioNTech SE
•Bavarian Nordic Inc.
•Advaxis Inc.
•Immatics NV
•Precision Biologics Inc.
•Iovance Biotherapeutics Inc.
•Agenus Inc.
•Achilles Therapeutics Plc
•Medigene AG
•Gritstone Bio Inc.
•SQZ Biotechnologies Company
•Aduro BioTech Inc.
•Inovio Pharmaceuticals Inc.
•Gradalis Inc.
•EpiVax Inc.
•ISA Pharmaceuticals BV
•Vaxon Biotech SA
•Ziopharm Oncology
•Genocea Biosciences Inc.
•Cellular Biomedicine Group Inc.
•Immunovaccine Inc.
What Are The Key Trends In The Neoantigen Targeted Therapies Market?
•Neoantigen resistance management
•Neoantigen-primed adoptive cell therapies
•Neoantigen-based combinatorial therapies
•Integration of real-world data
•Enhanced predictive models
What Are The Segments Of The Global Neoantigen Targeted Therapies Market?
•Type: Monotherapy, Combination Therapy
•Immunotherapy Type: DNA Or RNA-Based Vaccines, Protein-Based Vaccines, Dendritic Cell Vaccines, TIL-Based Therapies
•Target Disease Indication: Colorectal Cancer, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Bone Cancer, Gynecological Cancer
•Route Of Administration: Intradermal, Intravenous, Subcutaneous
•Application: Medical Research Institution, Hospital, And Clinic, Other Applications
Which Region Leads The Neoantigen Targeted Therapies Market?
North America was the largest region in the neoantigen targeted therapies market in 2024. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Pre-book the Report for Swift Delivery:
https://www.thebusinessresearchcompany.com/report/neoantigen-targeted-therapies-global-market-report
What Is Covered In The Neoantigen Targeted Therapies Market Global Market Report?
- Market Size Analysis: Analyze the Neoantigen Targeted Therapies Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Neoantigen Targeted Therapies Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Neoantigen Targeted Therapies Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Neoantigen Targeted Therapies Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Request Customization for This Report:
https://www.thebusinessresearchcompany.com/customise?id=11944&type=smp
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neoantigen Targeted Therapies Market: Towering Growth, Key Players, and Emerging Trends here
News-ID: 3834360 • Views: …
More Releases from The Business Research Company
2025-2034 Mainframe Modernization Market Evolution: Emerging Opportunities and M …
What Is the Projected Size of the Mainframe Modernization Market by 2025?
Recent years have witnessed substantial expansion in the market dedicated to mainframe modernization, with projections indicating a climb from a valuation of $15.72 billion in 2024 up to $18.12 billion by 2025, a trajectory translating to a compound annual growth rate (CAGR) of 15.2%. This historical upward trend is fueled by several key factors, chief among them being escalating…
Accelerated Digital Transformation Fuels Expansion in the Liquid Crystal Polymer …
How Much Will the Liquid Crystal Polymer (LCP)-Based Molded Interconnect Device Market Size Increase by 2025?
The market for liquid crystal polymer (LCP)-based molded interconnect devices has experienced swift augmentation recently, projected to escalate from a value of $0.64 billion in 2024 to $0.75 billion in 2025, reflecting a compound annual growth rate (CAGR) of 17.3%. This historical expansion is largely traceable to several key factors, including the wider acceptance of…
Consistent Growth Projected for Land-Based Command, Control, Communications, Com …
How Much Is the Land-Based Command, Control, Communications, Computers, Intelligence, Surveillance, And Reconnaissance( C4ISR ) Market Expected to Expand by 2025?
The terrestrial C4ISR sector has experienced robust expansion lately, projected to increase its valuation from $32.64 billion in 2024 to $34.87 billion the following year, reflecting a steady compound annual growth rate of 6.8%. This upward trajectory in the past phase is traceable to several key factors, including a more…
Surging Application Across End Users Powers the Expansion of the Intelligent Ele …
How Large Is the Intelligent Electrical Panel Market Expected to Be by 2025?
The electrical panel segment characterized by intelligence has experienced swift expansion recently, projected to escalate its valuation from a total of $4.47 billion in the year 2024 to $4.95 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 10.7%; this upward trajectory throughout the preceding period is linked to several factors, namely the escalating need for…
More Releases for Neoantigen
Neoantigen Targeted Therapies Market Trends, Innovations, and Forecast Analysis
Neoantigen targeted therapies are a revolutionary class of immunotherapies that aim to stimulate the body's immune system to recognize and attack cancer cells. Neoantigens are tumor-specific antigens that arise from mutations in the DNA of cancer cells. These mutations produce abnormal proteins that are not present in normal cells, making them ideal targets for immune system recognition. Neoantigen-based therapies focus on developing personalized treatments by targeting these unique antigens, making…
Neoantigen Cancer Vaccine Market Size, Share & CAGR 69.43% to 2034
What is driving the explosive growth of the neoantigen cancer vaccine market?
The neoantigen cancer vaccine market is seeing one of the most rapid growth trajectories in modern oncology. With a market size of USD 116.74 million in 2024, it is projected to reach USD 22,757.41 million by 2034, growing at a CAGR of 69.43%. This unprecedented growth is being fueled by advancements in genomic technologies, the success of mRNA platforms…
Rising Incidence Of Cancer Cases Drives Growth In The Neoantigen Targeted Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Neoantigen Targeted Therapies Industry Market Size Be by 2025?
There has been a notable expansion in the market size of neoantigen targeted therapies in the last few years. This market is projected to grow from $3.4 billion in 2024 to $4.72 billion in 2025, experiencing a…
Neoantigen Peptides Manufacturing Market Study Analysis with Forecast to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Neoantigen Peptides Manufacturing Market by Scale of operations (Research/Preclinical, Clinical, Commercial), by End-Users (Pharmaceutical/Vaccine developers companies, Contract Research Organizations (CRO), Academic and Research Institutes)- Trends, Industry Competition Analysis, Revenue and Forecast To 2030."
The Neoantigen Peptides Manufacturing Market is expected to grow at a 16.0 % CAGR during the forecast period for 2023-2031.
Request for Free Sample…
Neoantigen Peptide Manufacturing Market Research Report 2023 - InsightAce Analyt …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Neoantigen Peptides Manufacturing Market by Scale of operations (Research/Preclinical, Clinical, Commercial), by End-Users (Pharmaceutical/Vaccine developers companies, Contract Research Organizations (CRO), Academic and Research Institutes)- Trends, Industry Competition Analysis, Revenue and Forecast To 2030."
According to the latest research by InsightAce Analytic, the global Neoantigen Peptides Manufacturing market is expected to grow with CAGR of 16.4% during…
Latest Comprehensive Neoantigen Cancer Vaccine Market CAGR of 76% during forecas …
Neoantigen Cancer Vaccine Market Information:
Straits Research has recently added a new report to its vast depository titled Neoantigen Cancer Vaccine Market. The report studies vital factors about the Neoantigen Cancer Vaccine Market that are essential to be understood by existing as well as new market players. The report highlights the essential elements such as market share, profitability, production, sales, manufacturing, advertising, technological advancements, key market players, regional segmentation, and many…
